BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Erlotinib
1
Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis
3/22/2024 11:13:53 AM | Browse: 100 | Download: 355
2
Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report
8/24/2021 2:07:00 AM | Browse: 412 | Download: 1167
3
Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report
3/6/2019 8:51:28 AM | Browse: 828 | Download: 1393
4
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1207 | Download: 1665
5
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature
12/11/2014 2:06:00 PM | Browse: 963 | Download: 1275
6
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
9/15/2014 8:54:00 PM | Browse: 1252 | Download: 1093
7
FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer
9/15/2014 4:56:00 PM | Browse: 1100 | Download: 1218
8
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1159 | Download: 1198
9
Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells
8/26/2014 1:51:00 PM | Browse: 1017 | Download: 948
10
Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts
8/20/2014 6:38:00 PM | Browse: 1354 | Download: 1183
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345